Merck & Co. Inc. buy Royal Bank of Canada
Start price
08.07.26
/
50%
€111.06
Target price
08.07.27
€124.38
Performance (%)
17.59%
Price
21.08.26
€130.60
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 17.59%. This prediction currently runs until 08.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 11.206% | 11.206% |
| iShares Core DAX® | -1,28 % | 4,21 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % |
| iShares S&P 500 | -2,31 % | -0,10 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€102.80
30.03.26
30.03.26
€123.30
30.03.27
30.03.27
27.04%
21.08.26
21.08.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€105.40
25.02.26
25.02.26
€120.47
25.02.27
25.02.27
23.91%
21.08.26
21.08.26